(5S)-5-[3-chloro-7-[4-(4-methyl-1,2,5-oxadiazol-3-yl)piperazin-1-yl]thieno[2,3-c]pyridin-2-yl]-2,5-dimethyl-1,1-dioxo-6H-1,2,4-thiadiazin-3-amine | 1603136-29-3

• 分子结构分类: 有机化合物 - 有机杂环化合物 - 二嗪烷类
• 英文名称: (5S)-5-[3-chloro-7-[4-(4-methyl-1,2,5-oxadiazol-3-yl)piperazin-1-yl]thieno[2,3-c]pyridin-2-yl]-2,5-dimethyl-1,1-dioxo-6H-1,2,4-thiadiazin-3-amine
• CAS: 1603136-29-3
• 化学式: C₁₉H₂₃ClN₈O₃S₂
• 分子量: 511.028
• InChiKey: LPASGRSCSBQHPG-IBGZPJMESA-N

计算性质

• 辛醇/水分配系数(LogP)：
  1.5
• 重原子数：
  33
• 可旋转键数：
  3
• 环数：
  5.0
• sp3杂化的碳原子比例：
  0.47
• 拓扑面积：
  171
• 氢给体数：
  1
• 氢受体数：
  10

反应信息

• 作为产物：
  描述：

  tert-butyl N-[(5S)-5-(7-bromo-3-chlorothieno[2,3-c]pyridin-2-yl)-2,5-dimethyl-1,1-dioxo-6H-1,2,4-thiadiazin-3-yl]carbamate 、 3-methyl-4-(piperazin-1-yl)furazan 在 chloro-(2-dicyclohexylphosphino-2’,6’-diisopropoxy-1,1‘-biphenyl)[2-(2-aminoethyl)phenyl] palladium(ll) methyl-tert-butyl ether adduct 、 caesium carbonate 作用下， 以 四氢呋喃 为溶剂， 反应 18.0h， 生成 (5S)-5-[3-chloro-7-[4-(4-methyl-1,2,5-oxadiazol-3-yl)piperazin-1-yl]thieno[2,3-c]pyridin-2-yl]-2,5-dimethyl-1,1-dioxo-6H-1,2,4-thiadiazin-3-amine
  参考文献：
  名称：

  [EN] TRICYCLIC SUBSTITUTED THIADIAZINE DIOXIDE COMPOUNDS AS BACE INHIBITORS, COMPOSITIONS, AND THEIR USE
  [FR] COMPOSÉS DE DIOXYDE DE THIADIAZINE SUBSTITUÉE TRICYCLIQUE UTILISÉS EN TANT QU'INHIBITEURS DE BACE, COMPOSITIONS ET LEUR UTILISATION

  摘要：

  在其多种实施方式中，本发明提供了某些咪唑啉二氧化物化合物，包括化合物式（I）：（I）及其互变异构体和立体异构体，以及所述化合物的药用可接受盐，所述互变异构体和所述立体异构体，其中三环取代基的中间环（以下简称为“环B”）是一个可选择取代的6元环，以及在公式中所示的其余各变量均如本文所定义。该发明的新化合物可用作β-淀粉样蛋白前体蛋白酶（BACE）抑制剂和/或用于治疗和预防与之相关的各种病理学。还披露了包括一种或多种这样的化合物（单独和与一种或多种其他活性剂结合）的药物组合物，以及其制备和使用的方法，包括治疗阿尔茨海默病。

  公开号：

  WO2014062553A1

文献信息

• TRICYCLIC SUBSTITUTED THIADIAZINE DIOXIDE COMPOUNDS AS BACE INHIBITORS, COMPOSITIONS, AND THEIR USE
  申请人：Merck Sharp & Dohme Corp.

  公开号：EP2908824B1

  公开（公告）日：2018-05-02
• TRICYCLIC SUBSTITUTED THIADIAZINE DIOXIDE COMPOUNDS AS BACE INHIBITORS, COMPOSITIONS AND THEIR USE
  申请人：MERCK SHARP & DOHME CORP.

  公开号：US20150284379A1

  公开（公告）日：2015-10-08

  In its many embodiments, the present invention provides certain iminothiazine dioxide compounds, including compounds Formula (I): (I) and tautomers and stereoisomers thereof, and pharmaceutically acceptable salts of said compounds, said tautomers and said stereoisomers, wherein the middle ring (referred to herein as “ring B”) of the tricyclic substituent is an optionally substituted 6-membered ring, and each of the remaining variables shown in the formula are as defined herein. The novel compounds of the invention are useful as BACE inhibitors and/or for the treatment and prevention of various pathologies related thereto. Pharmaceutical compositions comprising one or more such compounds (alone and in combination with one or more other active agents), and methods for their preparation and use, including Alzheimer's disease, are also disclosed.
• US9416129B2
  申请人：——

  公开号：US9416129B2

  公开（公告）日：2016-08-16
• [EN] TRICYCLIC SUBSTITUTED THIADIAZINE DIOXIDE COMPOUNDS AS BACE INHIBITORS, COMPOSITIONS, AND THEIR USE<br/>[FR] COMPOSÉS DE DIOXYDE DE THIADIAZINE SUBSTITUÉE TRICYCLIQUE UTILISÉS EN TANT QU'INHIBITEURS DE BACE, COMPOSITIONS ET LEUR UTILISATION
  申请人：MERCK SHARP & DOHME

  公开号：WO2014062553A1

  公开（公告）日：2014-04-24

  In its many embodiments, the present invention provides provides certain iminothiazine dioxide compounds, including compounds Formula (I): (I) and tautomers and stereoisomers thereof, and pharmaceutically acceptable salts of said compounds, said tautomeros and said stereoisomers, wherein the middle ring (referred to herein as "ring B") of the tricyclic substituent is an optionally substituted 6-membered ring, and each of the remaining variables shown in the formula are as defined herein. The novel compounds of the invention are useful as BACE inhibitors and/or for the treatment and prevention of various pathologies related thereto. Pharmaceutical compositions comprising one or more such compounds (alone and in combination with one or more other active agents), and methods for their preparation and use, including Alzheimer's disease, are also disclosed.

  在其多种实施方式中，本发明提供了某些咪唑啉二氧化物化合物，包括化合物式（I）：（I）及其互变异构体和立体异构体，以及所述化合物的药用可接受盐，所述互变异构体和所述立体异构体，其中三环取代基的中间环（以下简称为“环B”）是一个可选择取代的6元环，以及在公式中所示的其余各变量均如本文所定义。该发明的新化合物可用作β-淀粉样蛋白前体蛋白酶（BACE）抑制剂和/或用于治疗和预防与之相关的各种病理学。还披露了包括一种或多种这样的化合物（单独和与一种或多种其他活性剂结合）的药物组合物，以及其制备和使用的方法，包括治疗阿尔茨海默病。